phenelzine (Q1747559)

Phenelzine (English)

3 October 2016

C₈H₁₂N₂

1 reference

Phenelzine (English)

19 November 2016

C1=CC=C(C=C1)CCNN

1 reference

https://www.whocc.no/atc_ddd_index/?code=N06AF03

Phenelzine (English)

19 November 2016

60 milligram

route of administration

oral administration

1 reference

reference URL

1 reference

14 February 2018

medical condition treated

1 reference

significant drug interaction

13 December 2016

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

entacapone

increased systemic arterial blood pressure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

guanethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

midodrine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

norepinephrine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

epinephrine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

depressed level of consciousness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

depressed level of consciousness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bupropion

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tetrabenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

muscle stiffness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

palpitation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tolcapone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

guanethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

entacapone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tetrabenazine

increase in blood catecholamines

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Amine oxidase copper containing 3

1 reference

cytochrome P450 family 2 subfamily C member 8

17 August 2016

1 reference

solute carrier family 6 member 3

17 August 2016

1 reference

17 August 2016

1 reference

17 August 2016

1 reference

Solute carrier family 6 member 2

17 August 2016

1 reference

solute carrier family 6 member 4

17 August 2016

1 reference

17 August 2016

1 reference

Open Targets Platform

https://platform.opentargets.org/drug/CHEMBL1089

14 August 2023

reference URL

1 reference

Open Targets Platform

https://platform.opentargets.org/drug/CHEMBL1089

14 August 2023

reference URL

pregnancy category

Australian pregnancy category B3

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

1 reference

https://www.pfizer.com/products/product-list

monoamine oxidase inhibitor

2 references

5 March 2018

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

Phenelzine

0 references

Identifiers

InChI

InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2

1 reference

Phenelzine (English)

19 November 2016

2 references

Phenelzine (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

51-71-8

2 references

phenelzine (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=51-71-8

9 April 2021

1 reference

Phenelzine (English)

3 October 2016

2 references

Phenelzine (English)

19 November 2016

ChEBI ID

8060

mapping relation type

2 references

PHENELZINE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2

1 reference

PHENELZINE (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Fac_Eng_Univ_Tokyo-JP003847

1 reference

Merck Index monograph

m8605

0 references

MassBank accession ID

0 references

SPLASH

splash10-0002-9000000000-833e467e14c48ae4f6b3

0 references

HSDB ID

8127

1 reference

Hazardous Substances Data Bank

28 October 2019

Phenelzine (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

1 reference

phenelzine (English)

ECHA Substance Infocard ID

19 November 2016

100.000.108

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Phenelzine (English)

CAS no.: 51-71-8 (English)

1 reference

Phenelzine (English)

publication date

17 November 2015

1 reference

phenelzine (English)

19 November 2016

Phenelzine

0 references

0 references

0 references

1 reference

phenelzine (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0014918

2 references

based on heuristic

inferred from InChIKey

2 references

phenelzine (English)

19 November 2016

MedlinePlus drug identifier

a682089

0 references

PatientsLikeMe treatment ID

0 references

1 reference

phenelzine (English)

19 November 2016

0 references

1 reference

1 reference

Phenelzine (English)

3 October 2016

1 reference

Phenelzine (English)

Encyclopædia Britannica Online ID

3 October 2016

science/phenelzine

subject named as

phenelzine

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

UK Parliament thesaurus ID

471728

subject named as

Phenelzine

0 references

UMLS CUI

C0031392

1 reference

phenelzine (English)

19 November 2016

0 references

WordNet 3.1 Synset ID

03927871-n

1 reference